Literature DB >> 20937007

Gonadal status and physical performance in older men.

Marcello Maggio1, Gian Paolo Ceda, Fulvio Lauretani, Stefania Bandinelli, Earl Jeffrey Metter, Jack M Guralnik, Shehzad Basaria, Chiara Cattabiani, Michele Luci, Elisabetta Dall'Aglio, Alessandro Vignali, Riccardo Volpi, Giorgio Valenti, Luigi Ferrucci.   

Abstract

OBJECTIVE: To test the relationship between gonadal status and objective measures and determinants of physical performance in older men and their determinants.
METHODS: The study included 455 ≥ 65 year older men of InCHIANTI study, Italy, with complete data on testosterone levels, hand grip strength, cross-sectional muscle area (CSMA), short physical performance battery (SPPB). Linear models were used to test the relationship between gonadal status and determinants of physical performance.
RESULTS: Three different groups of older men were created: (1) severely hypogonadal (N=23), total testosterone levels ≤ 230 ng /dl; (2) moderately hypogonadal (N=88), total testosterone >230 and < 350 ng/dl) and (3) eugonadal (N=344), testosterone levels ≥ 350 ng/dl. With increased severity of hypogonadal status, participants were significantly older while their BMI was substantially similar. In the age and BMI adjusted analysis, there was a significant difference in haemoglobin levels, hand grip strength and SPPB score (p for trend < 0.001) among three groups, with severely hypogonadal men having lower values of haemoglobin, muscle strength and physical performance. We found no association between testosterone group assignment and calf muscle mass and 4 m walking speed. In the multivariate analysis grip strength (p for trend = 0.004) and haemoglobin (p for trend < 0.0001) but not SPPB and other determinants of physical performance were significantly different between the three groups.
CONCLUSIONS: In older men, gonadal status is independently associated with some determinants (haemoglobin and muscle strength) of physical performance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937007      PMCID: PMC3142745          DOI: 10.3109/13685538.2010.518179

Source DB:  PubMed          Journal:  Aging Male        ISSN: 1368-5538            Impact factor:   5.892


  25 in total

Review 1.  Consensus Document on substitution therapy with testosterone in hypoandrogenic elderly men.

Authors:  Giorgio Valenti; Simonetta Bossoni; Andrea Giustina; Domenico Maugeri; Massimo Motta; Giovanni B Vigna; Renato Fellin; Francesco Corica; Andrea Corsonello; Giuseppe Paolisso; Mario Barbagallo; Ligia Dominguez; Licia Denti; GianPaolo Ceda; Ettore Ferrari; Barbara Pontiggia; Felix Strollo
Journal:  Aging Clin Exp Res       Date:  2002-12       Impact factor: 3.636

2.  Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male.

Authors:  A Morales; B Lunenfeld
Journal:  Aging Male       Date:  2002-06       Impact factor: 5.892

3.  Treatment of androgen deficiency in the aging male.

Authors: 
Journal:  Fertil Steril       Date:  2004-05       Impact factor: 7.329

4.  Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline.

Authors:  Shalender Bhasin; Glenn R Cunningham; Frances J Hayes; Alvin M Matsumoto; Peter J Snyder; Ronald S Swerdloff; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2006-05-23       Impact factor: 5.958

5.  Mobility in older adults: a comprehensive framework.

Authors:  Sandra C Webber; Michelle M Porter; Verena H Menec
Journal:  Gerontologist       Date:  2010-02-09

6.  A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission.

Authors:  J M Guralnik; E M Simonsick; L Ferrucci; R J Glynn; L F Berkman; D G Blazer; P A Scherr; R B Wallace
Journal:  J Gerontol       Date:  1994-03

7.  Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study.

Authors:  L Ferrucci; S Bandinelli; E Benvenuti; A Di Iorio; C Macchi; T B Harris; J M Guralnik
Journal:  J Am Geriatr Soc       Date:  2000-12       Impact factor: 5.562

8.  Testosterone administration to older men improves muscle function: molecular and physiological mechanisms.

Authors:  Arny A Ferrando; Melinda Sheffield-Moore; Catherine W Yeckel; Charles Gilkison; Jie Jiang; Alison Achacosa; Steven A Lieberman; Kevin Tipton; Robert R Wolfe; Randall J Urban
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-03       Impact factor: 4.310

9.  American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update.

Authors:  Steven M Petak; Howard R Nankin; Richard F Spark; Ronald S Swerdloff; Luis J Rodriguez-Rigau
Journal:  Endocr Pract       Date:  2002 Nov-Dec       Impact factor: 3.443

10.  Long-term effects of androgen deprivation therapy in prostate cancer patients.

Authors:  Shehzad Basaria; John Lieb; Alice M Tang; Theodore DeWeese; Michael Carducci; Mario Eisenberger; Adrian S Dobs
Journal:  Clin Endocrinol (Oxf)       Date:  2002-06       Impact factor: 3.478

View more
  12 in total

Review 1.  Physiology and its importance for reference intervals.

Authors:  Kenneth A Sikaris
Journal:  Clin Biochem Rev       Date:  2014-02

Review 2.  Aging and sex hormones in males.

Authors:  Maria Chiara Decaroli; Vincenzo Rochira
Journal:  Virulence       Date:  2016-11-10       Impact factor: 5.882

Review 3.  Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases.

Authors:  Rita Rastogi Kalyani; Mark Corriere; Luigi Ferrucci
Journal:  Lancet Diabetes Endocrinol       Date:  2014-03-06       Impact factor: 32.069

Review 4.  Predicting low testosterone in aging men: a systematic review.

Authors:  Adam C Millar; Adrian N C Lau; George Tomlinson; Alan Kraguljac; David L Simel; Allan S Detsky; Lorraine L Lipscombe
Journal:  CMAJ       Date:  2016-06-20       Impact factor: 8.262

Review 5.  Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons.

Authors:  Marcello Maggio; Fulvio Lauretani; Francesca De Vita; Shehzad Basaria; Giuseppe Lippi; Valeria Butto; Michele Luci; Chiara Cattabiani; Graziano Ceresini; Ignazio Verzicco; Luigi Ferrucci; Gian Paolo Ceda
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 6.  Androgen effects on skeletal muscle: implications for the development and management of frailty.

Authors:  Matthew D L O'Connell; Frederick C W Wu
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

7.  Testosterone in advance age: a New Zealand longitudinal cohort study: Life and Living in Advanced Age (Te Puāwaitanga o Ngā Tapuwae Kia Ora Tonu).

Authors:  Martin J Connolly; Ngaire Kerse; Tim Wilkinson; Oliver Menzies; Anna Rolleston; Yih Harng Chong; Joanna B Broad; Simon A Moyes; Santosh Jatrana; Ruth Teh
Journal:  BMJ Open       Date:  2017-11-12       Impact factor: 2.692

8.  Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS).

Authors:  Rajib K Bhattacharya; Mohit Khera; Gary Blick; Harvey Kushner; Martin M Miner
Journal:  Clin Interv Aging       Date:  2012-08-24       Impact factor: 4.458

Review 9.  The Role of the Multiple Hormonal Dysregulation in the Onset of "Anemia of Aging": Focus on Testosterone, IGF-1, and Thyroid Hormones.

Authors:  Marcello Maggio; Francesca De Vita; Alberto Fisichella; Fulvio Lauretani; Andrea Ticinesi; Graziano Ceresini; Anne Cappola; Luigi Ferrucci; Gian Paolo Ceda
Journal:  Int J Endocrinol       Date:  2015-12-08       Impact factor: 3.257

Review 10.  Pulmonary rehabilitation: the reference therapy for undernourished patients with chronic obstructive pulmonary disease.

Authors:  Nikolaos Samaras; Dimitrios Samaras; Arnaud Chambellan; Claude Pichard; Ronan Thibault
Journal:  Biomed Res Int       Date:  2014-02-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.